ArticleBlood advances2026

Allele-selective disruption of pathogenic VWF variants in type 2 von Willebrand disease using CRISPR/Cas9.

Isabel Bär et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.